🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06101030
Recruiting Observational

Comparing Use of Incentive Spirometry With and Without Reminder

NCT06101030 · tracked via the Priya Life Science USA tracker
Sponsor
Tidal Medical Technologies
Phase
Observational
Started
2024-01-16
Last updated
2025-04-10

Condition(s) studied

Post Operative

Investigational drug(s) / intervention(s)

Signal On

Signal On: InSee monitor patient signals are on.

Study summary

This study is designed to determine if patients using an incentive spirometer with visual and auditory signals will increase their use of the incentive spirometer and prevent lung complications.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: Patients must meet all the following Inclusion criteria to be eligible for participation in the study: * Patient has undergone a qualifying surgical procedure. * Patient is aged 18 years or over. * Patient has incentive spirometry ordered or incentive spirometry must be part of the study site's standard of care which is implemented by hospital staff. * Patient is able to comply with all study required incentive spirometry instructions. * Patient is without severe hearing or impaired visual acuity deficiency such that they cannot hear or see the audible and visual signal for the InSee monitor. Exclusion Criteria: * Patients meeting any of the following exclusion criteria at baseline will be excluded from study participation: * Vulnerable Populations (Pregnant, minors, prisoners, those with significantly reduced mental acuity). * Patients where incentive spirometry is inappropriate (patients with Tractotomy, patients who are hemodynamically unstable, patients in reverse isolation due to infection). * Patients with a history of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction), or cognitive issue which would in the opinion of the investigator, make it difficult for the patient to comply with the study procedures or follow the investigators instructions. * Any medical condition that, in the opinion of the investigator, would place the patient at increased risk if they participated. * Any Physician determination that the patient should not participate.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Tidal Reseach Site Silver Spring Maryland Terminated
Tidal Study Site Rochester Minnesota Recruiting
Tidal Study Site New Brunswick New Jersey Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06101030 on ClinicalTrials.gov ↗ ← All trials in the USA